RBP news

Latest 1 stories · newest Nov 2, 2026

RBP

Regen BioPharma sells $125K promissory note to Coventry Enterprises

Regen BioPharma entered into a securities purchase agreement with Coventry Enterprises, LLC, for a $125,000 promissory note convertible to common stock, exempt from registration under Regulation D.

Offering Nov 2, 2026 sentiment -0.30 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same RBP feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/RBP/newsSTART FREE